Prospects for development of a vaccine to prevent and control vaginal candidiasis.
about
New insights on the development of fungal vaccines: from immunity to recent challengesIL-22 and IDO1 affect immunity and tolerance to murine and human vaginal candidiasisβ-Glucan induces reactive oxygen species production in human neutrophils to improve the killing of Candida albicans and Candida glabrata isolates from vulvovaginal candidiasisPropolis Is an Efficient Fungicide and Inhibitor of Biofilm Production by Vaginal Candida albicans.IL-17 signaling in host defense against Candida albicans.A Candida albicans Strain Expressing Mammalian Interleukin-17A Results in Early Control of Fungal Growth during Disseminated Infection.Molecular recognition of Candida albicans (1->2)-β-mannan oligosaccharides by a protective monoclonal antibody reveals the immunodominance of internal saccharide residues.New approaches in the development of a vaccine for mucosal candidiasis: progress and challengesRecent progress in vaccines against fungal diseasesFungal cell wall vaccines: an update.Antibody recognition of carbohydrate epitopes†.Designing a new antifungal glycoconjugate vaccine.Adjuvants and delivery systems for antifungal vaccines: current state and future developments.Beyond Candida albicans: Mechanisms of immunity to non-albicans Candida speciesVulvovaginal candidosis: contemporary challenges and the future of prophylactic and therapeutic approaches.Humoral immune responses to Candida albicans complement receptor 3-related protein in the atopic subjects with vulvovaginal candidiasis. Novel sensitive marker for Candida infection.Shedding natural light on fungal infections.Candida Immunity
P2860
Q26776056-B7A7460F-B756-4D57-B719-05C582867352Q28534626-36DA119D-98FF-45AB-A0B5-281082B5E9ADQ34208636-B949E835-DD56-44D0-93AD-D70312886CC4Q35178115-41190072-BAC9-48C0-908E-602B86A93C82Q35671394-031FD1FE-839E-49EA-8360-B41F487F937BQ35947439-EDB05894-7F68-43B7-A724-1F201D5CF7DFQ36002863-9BBF0A19-EF3E-4281-8251-75AA54528986Q36158337-8CF9FF86-5C56-4B00-8117-3926CB4C080CQ36179629-941D75F5-3D67-417D-AD76-28AE37BD4710Q36525342-BDFE234B-7303-4E50-9CB2-392D0BC5E6A2Q37840398-3CBAAAD8-E259-4401-9124-097304CB48BCQ38066728-7DB078BF-A239-41D2-9308-26D0273EF5EEQ38264288-1D13DC69-5AF6-4F48-A2EC-FB4DE48BA244Q38567197-65927C76-A71C-4C18-A1BC-8CB0815E77EFQ38696236-2C767EEE-38E9-4E48-8F77-3C0403B18C54Q41488648-1606A5A0-E9ED-488F-8B54-2C4A43533715Q50664744-89F96F9C-6F97-4ADA-80C2-27095851FC9AQ59072636-1719CD21-9E87-4DDE-ABC2-5A34CD853640
P2860
Prospects for development of a vaccine to prevent and control vaginal candidiasis.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Prospects for development of a vaccine to prevent and control vaginal candidiasis.
@ast
Prospects for development of a vaccine to prevent and control vaginal candidiasis.
@en
Prospects for development of a vaccine to prevent and control vaginal candidiasis.
@nl
type
label
Prospects for development of a vaccine to prevent and control vaginal candidiasis.
@ast
Prospects for development of a vaccine to prevent and control vaginal candidiasis.
@en
Prospects for development of a vaccine to prevent and control vaginal candidiasis.
@nl
prefLabel
Prospects for development of a vaccine to prevent and control vaginal candidiasis.
@ast
Prospects for development of a vaccine to prevent and control vaginal candidiasis.
@en
Prospects for development of a vaccine to prevent and control vaginal candidiasis.
@nl
P2860
P1476
Prospects for development of a vaccine to prevent and control vaginal candidiasis.
@en
P2093
Jim E Cutler
Paul L Fidel
P2860
P304
P356
10.1007/S11908-010-0143-Y
P577
2011-02-01T00:00:00Z